Upstream Bio, Inc. (UPB) — 10-Q Filings
All 10-Q filings from Upstream Bio, Inc.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Upstream Bio's Losses Mount as R&D Soars for Key Drug Candidate
— Nov 5, 2025 Risk: high
Upstream Bio, Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $100.98 million, a substantial rise from $ -
Upstream Bio's Q2 Net Loss Widens to $45.2M Amid R&D Push
— Aug 6, 2025 Risk: high
Upstream Bio, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company's net loss for th -
Upstream Bio, Inc. Files Q1 2025 10-Q
— May 6, 2025 Risk: medium
Upstream Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position and business activities, including detail
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX